View Article

Abstract

A simple, precise and accurate RP-HPLC method was developed and validated for the estimation of Metoprolol Succinate in pharmaceutical dosage form. Chromatographic separation was achieved on a column C18 (250 mm x 4.6 mm,5µm) using methanol and 0.1% v/v triethylamine in the ratio of (70:30) at a flow rate of 1.0?l , detection wavelength of 234nm and injection volume of 10 micro liter. The drug showed a retention time of 6.8 minutes and good linearity over the concentration range of 0.5, 0.75, 1, 1.25 and 1.5?g/ml with a regression coefficient of 0.999. Percentage recovery was 98-100% and percentage standard deviation was below less than 2%. LOD and LOQ indicated adequate sensitivity. The method complies with ICH guidelines and suitable for routine quality control analysis.

Keywords

Metoprolol Succinate, RP-HPLC method, Method validation and Pharmaceutical dosage form.

Introduction

Metoprolol succinate is a selective β-adrenergic receptor blocker widely used in the management of various cardiovascular disorders. It is primarily indicated for the treatment of hypertension, angina pectoris, heart failure and for the prevention of myocardial infraction. By selectively inhibiting β1 receptors in the heart, metoprolol reduces heart rate, myocardial contractility and cardiac output thereby reducing blood pressure and decreasing the oxygen demand of the heart. Metoprolol succinate is well absorbed after oral administration and undergoes hepatic metabolism, mainly by cytochrome P450 enzyme. This drug is commonly prescribed in long term cardiovascular therapy.

DRUG PROFILE:

Figure.no:1 Chemical structure of Metoprolol succinate

IUPAC Name: ?4-(2-methoxy ethyl) phenoxy?-3-?1-methyl ethyl amino?-2-propane butanedioate.

Molecular formula: C34H56N2O10                       

Molecular weight: 652.82g/mol

Solubility: Methanol and  Purified water

MECHANISM OF ACTION:

Metoprolol succinate is a cardio selective, β1-adrengeric receptor blocker that lowers heart rate, blood pressure and cardiac workload by competitively inhibiting catecholamine binding in the heart. As a long-acting extended-release formulation, it provides sustained 24-hours antagonism, reducing renin secretion and reducing oxygen demand making it effective for the hyper tension, angina and heart failure.

RP-HPLC METHOD

Chromatographic Condition

The isocratic mobile phase consisting of methanol and  0.1%Triethylamine in the ratio of (70:30), flowing through the column and constant flow rate of 1.0ml/min. The mobile phase was filtered through 0.45µm membrane filter and was degassed before used 30 mins. C18 Column (250 mm x 4.6 mm,5µ) as used as a stationary phase.

MATERIALS AND METHODS:

Drug Sample and Formulation used

Metoprolol Succinate bulk  drug  were Gifted By Madras Pharma,  Chennai.

Brand Name

Labeled Name

Source

ACLOMET – XL

25mg

M.R healthcare Pvt, Ltd

Chemicals and Solvents used

All the Chemicals Used were of analytical Grade as well as HPLC grade procured from Great scientific Laboratory and Sumison Laboratory from Tiruvannamalai and Chennai.

The Chemical used for the Study were,

  • Methanol (HPLC GRADE)
  • Milli-Q Water (HPLC WATER)
  • Triethylamine Buffer (Analytical grade)

Apparatus and Glassware’s

  • 100ml volumetric flask
  • 10ml volumetric flask
  • Beakers
  • Glass rod, etc.

Instruments

Instruments employed for the study were,

  1. SHIMADZU AUX – 220 DIGITAL BALANCE
  2. SIMADZU prominence HPLC iLC2030 plus
  3. Sonica Ultra Sonic Cleaner-Model 2200 plus
  4. ELICO PH Meter (Model LI -120)
  5. Melting Point Apparatus.

METHOD DEVELOPMENT:

Prepartion of Mobile Phase

  1. For Trail Chromatogram of Metoprolol Succinate:

Methanol and 0.1 % v/v of Triethylamine in milli-q water(60:40) was taken into a 1000 ml volumetric flask and mixed properly. Then, this mobile phase is sonicated for 15 min and used as the mobile phase by isocratic elution method.

  1. For Optimized Chromatogram of Metoprolol Succinate:

Methanol and 0.1 % v/v of Triethylamine  in milli-q water (70:30)  was taken into a 1000 ml volumetric flask and mixed properly. Then, this mobile phase is sonicated for 15 min and used as the mobile phase by isocratic elution method.

Preparation of Standard Solution

Accurately weighed 25 mg of metoprolol succinate and transferred into 100 ml volumetric flask and dissolved with (methanol and 0.1 % v/v of Triethylamine Solution (70:30) ) are added and to adjusted the volume up to the mark of volumetric Flask. From this 1ml was taken and added into 10ml volumetric flask with mobile phase are added and to adjusted the volume upto the mark of the volumetric flask.

Initial Separation Condition: Trail 1

For Method Development of Metoprolol Succinate Using to conducted the First trial injections were performed with mobile phase of  Methanol and 0.1 % v/v of Triethylamine in milli-q water (60:40) . 

Stationary Phase

C18 Column (250 mm x 4.6 mm,5µ)

Mobile Phase (v/v)

60:40 v/v

Injection Volume (ml/min)

10 micro litre

Flow Rate (ml/min)

1 ml/min

Column Temperature

25 °C

Wavelength (nm)

234nm

Chromatogram Of Trail 1

Sr. No

Retention Time

Area

Height

Theoretical Plate

Tailing Factor

1

14.966

141047

5316

7491

1.177

 

Metoprolol Succinate – Optimized Chromatogram:

We get Optimized Chromatogram with 70:30 ratios of mobile phases of Methanol and 0.1 % v/v of Triethylamine in milli-q water to identify the best chromatographic conditions.

Chromatographic   Condition

Description

Stationary Phase

C18 Column (250 mm x 4.6 mm,5µ)

Mobile Phase(v/v)

70:30 v/v

Injection Volume (ml/min)

10 micro liter

Flow Rate (ml/min)

1 ml/min

Column Temperature

25 °C

Wavelength(nm)

234n

 

 

Optimized Chromatogram

Sr. No

Retention Time

Area

Height

Theoretical Plate

Tailing Factor

1

6.836

180226

10944

4866

1.535

 

VALIDATAION PARAMETERS:

A. Linearity

Linearity studies were carried out in the concentration range of 0.5μg/ml, 0.75μg/ml, 1μg/ml, 1.25μg/ml and 1.5μg/ml.  The sample solution was made from the stock solution the readings were obtained by measuring the absorbance at 234 nm and presented in table and linearity curve.

 

Sr. No

Concentration

(Μg/Ml)

Peak Area

Correlation Coefficient

Lod

Loq

Slope

Intercept

1.

0.5

88270

0.999

4.55519

0.00013

25313

1094.6

2.

0.75

124945

3.

1

159642

4.

1.25

199542

5.

1.5

236187

 

Linearity Chromatogram in 50%

Sr. No

Retention Time

Area

Theoretical Plate

Tailing Factor

1

6.916

118696

4543

1.701

Linearity Chromatogram in 75%

Sr. No

Retention Time

Area

Theoretical Plate

Tailing Factor

1

6.924

156838

4676

1.542

Linearity Chromatogram in 100%

SR. NO

RETENTION TIME

AREA

THERIOTICAL PLATE

TAILING FACTOR

1

6.931

189540

4659

1.541

Linearity Chromatogram in 125%

Sr. No

Retention Time

Area

Theoretical Plate

Tailing Factor

1

6.930

170930

4724

1.504

Linearity Chromatogram in 150%

Sr. No

Retention Time

Area

Theoretical Plate

Tailing Factor

1

6.929

213622

4752

1.500

 

B. Accuracy

Accuracy of the method was evaluated by the standard addition technique at three concentration levels of 80%, 100%, and 120%. Known amount of standard drug solution were added to the pre - analyzed sample to be applied final concentration 20µg/ml, 25µg/ml and 30µg/ml. The solution were diluted with mobile phase composed of Methanol and 0.1%Triethylamine in Water. In the ratio of 70:30 and analyzed  under optimized condition.    

 

Sr. No

%

Concentration

Average

Area

Amount

Added (mg)

% Recovery

Mean Recovery

SD

%

RSD

1.

80%

150665

20

101.49

 

101.29

263.21

131.87

139.17

0.1747

0.0702

0.0627

2.

100%

187760

25

101.89

3.

120%

221829

30

100.49

Accuracy Chromatogram in 80%

Retention Time

Injection

Area

Theoretical plate

Tailing factor

6.929

1

150665

4703

1.558

 

Accuracy Chromatogram in 100%

 

Retention Time

Injection

Area

Theoretical plate

Tailing factor

6.924

2

187760

4955

1.477

Accuracy Chromatogram in 120%

Retention Time

Injection

Area

Theoretical plate

Tailing factor

6.917

3

221829

4988

1.443

The  %RSD value less than 2% was found.

C. Precision

1ml of stock solution was pipetted out into 10ml volumetric flask diluted upto mobile phase with the mark. Mixed well and filtered through 0.45µm filter. Therefore, the concentration of the resultant solution was 25µg/ml. The solution was taken and injected for five times within the same day and the chromatogram was recorded. The peak area was measured to calculate the % Relative standard deviation value.

Chromatogram of Precision

Table: Interday Precision

Sr. No

Peak Area

Average

SD

%RSD

1.

186229

186557.3

249.54

0.1337

2.

186347

3.

186542

4.

186721

5.

186920

6.

186585

Table: Intraday Precision

Sr. No

Peak Area

Average

SD

%RSD

1.

189229

186557.3

249.54

0.1337

2.

189347

3.

189542

4.

189721

5.

189920

6.

189585

The %RSD Value less Than 2% was Found. So the  method is highly precise and reproducible.

D. Robustness:

The robustness of the method was determined by introducing small changes in HPLC parameters such as changing in wavelength.

 

Sr. No

Wavelength (Nm)

Peak Area

Average Area

SD

%RSD

1

232

188371

186017.66

542.844

0.2873

2

234

180226

3

236

189456

 

E. RUGGEDNESS:

The ruggedness of the proposed method was evaluated by applying the developed procedure assay of 25μg/ml of Metoprolol Succinate using the same instrument by two different analyst under the same optimized conditions at different days.

 

Sr. No

Analyte

Concentration (µg/ml)

Peak Area

SD

%RSD

1.

ANALYTE-1

25

188012

466.750

0.24765

25

188452

25

188945

2.

ANALYTE-2

25

190390

153.206

0.08047

25

190344

25

190232

 

SUMMARY

Summary of Method Development:

Method Development Protocols Analytical method development is a systematic process used to establish a reliable, accurate, and reproducible procedure for the identification, quantification, and analysis of pharmaceutical substances. The primary objective is to develop a method that is specific, sensitive, precise, and robust, suitable for routine quality control and regulatory compliance. The protocol begins with a thorough understanding of the physicochemical properties of the drug substance, including solubility, pKa, polarity, and stability. Based on these properties,  HPLC analytical For chromatographic methods, initial conditions such as stationary phase, mobile phase composition, pH, flow rate, and detection wavelength are optimized to achieve good resolution, symmetrical peaks, and acceptable retention time. Subsequently, method optimization is carried out by systematic variation of experimental parameters to enhance performance characteristics.

Summary of Validation Parameters:

Once optimized, the developed method is subjected to method validation in accordance with ICH guidelines (Q2(R1)), ensuring suitability for its intended purpose. Validation parameters include specificity, linearity, accuracy, precision, robustness, and ruggedness. Finally, system suitability testing and documentation are performed to confirm consistent performance. A well-developed and validated analytical method ensures reliable drug analysis, supports stability studies, and plays a crucial role in maintaining pharmaceutical product quality and regulatory acceptance.

Sr. No

Validation Parameter

Objective

Procedure Summary

Acceptance Criteria

Results

1

Linearity

Proportional response

5–6 concentration levels

r² ≥ 0.998

0.999

2

Accuracy

Closeness to true value

Recovery at 80, 100, 120%

98–102%

101.29

3

Intraday Precision

Reproducibility

Different days/analysts

%RSD ≤ 2

0.1152

4

Interday precision

Reproducibility

Within a days/analysts

%RSD ≤ 2

0.1337

5

Robustness

Method reliability

Small deliberate variations

No significant change

No significant change

6

Ruggedness

Inter-lab precision

Different instruments/analysts

%RSD ≤ 2

Within the limit

CONCLUSION:

In this project, an RP-HPLC method was developed and validated for the estimation of metoprolol succinate in bulk and tablet dosage form. The method was found to be simple, fast, accurate and precise. All validation parameters such as linearity, accuracy, precision and robustness were within acceptable limits. Therefore, this RP-HPLC method is suitable for routine quality control analysis of metoprolol succinate in pharmaceutical formulation.

REFERENCES

  1. International Conference for Harmonization, Q2 (R1), Harmonized tripartite guidelines, validation of analytical procedures: text and methodology, Geneva, 2005;1-13.
  2. Martindale: The complete drug reference. Metoprolol Monograph – The pharmaceutical press 2007.
  3. Shashank Soni., Veerma Ram., Divya Verma., Anurag Verma., et.al. Analytical Method Development And Validation of Metoprolol Succinate by HPLC and UV Spectroscopy Technique. Research J. pharm an Tech.2021;14(2):937.doi.10.5958/0974-360X.2021.00166.9.
  4. Hemangi Somnath Chaudhari.,javesh K.Patil.,et.al. A Novel RP-HPLC Method for the Development and validation of Metoprolol Succinate in Bulk and Pharmaceutical Dosage Form. Asian Journal of pharmaceutical Analysis. 2025; doi.10.52711/2231-5675.2025.00045.
  5. Santhosh Kumar Bhardwaj.,K.Dwivedi and D.D.Agarwal.,et.al. A Review HPLC Method Development and Validation. International Journal of Analytical and Bioanalytical Chemistry.2015;5(4):76-81.
  6. Sathe SR, Bari SB, Surana SJ. Development of HPTLC method for the estimation of Metoprolol succinate in bulk and in tablet dosage form. Indian J.Pharm. Educ. Res., 42(1):32-35, 2008.
  7. Vaijanath GD, Sweta BS, et al, Simultaneous determination of Metoprolol succinate and Amlodipine besylate in pharmaceutical dosage form by HPLC, Journal of Pharmaceutical and Biomedical Analysis, 2008, 46(3),583–586.55.
  8. Singh B, Patel DK and Ghosh SK, Development of Reverse-Phase HPLC Method for Simultaneous Analysis of Metoprolol Succinate and Hydrochlorothiazide in a Tablet Formulation, Tropical Journal of Pharmaceutical Research, 2009, 8(6),539-543.
  9. Rajamanickam V, Stephen RB, et al, A validated RP-HPLC method of Metoprolol Succinate and Amlodipine Succinate from bulk drugs, Scholars Research Library, Der Pharmacia Lettre 2010, 2(4), 40-6.
  10. Al ARM, Spoorthy N, et al, Simultaneous estimation of Metoprolol succinate & Telmisartan in tablet dosage form by RP-HPLC, Journal of Pharmacy Research, 2012, 5(8), 4585.
  11.  Mitesh DP and Purnima DH, A Validated and Simplified RP-HPLC of Metoprolol Succinate from Bulk Drugs, Asian J. Research Chem, 2009,2(2),119-122.
  12. Prasad Rao CHMM, Rahaman SA, et al, RP-HPLC method of simultaneous estimation of Amlodipine besylate and Metoprolol in combined dosage form, International Journal of Pharma Research and Development, 2010, 2(9), 69-76.
  13. Mitesh DP, Purnima DH. A validated and simplified RPHPLC of Metoprolol succinate from bulk drugs. Asian Journal Research Chem 2009; 2(2): 119-122
  14. Aqil M, Ali A, Ahad A, Sultana Y, Najmi AK, Saha N. A validated HPLC method for estimation of metoprolol in human plasma. Acta Chromatographic a 2007; 19: 130-40.
  15. Sohan S Chitlange, Ramesh D Bhusil, Monesh B Nikumbh and Rithesh P Bhole, Development and validation of Spectrophotometric and stability indicating RP-HPLC Method for the simultaneous estimation of Metoprolol Succinate and Hydrochlorothiazide in tablet dosage form, International journal of pharmacy, 2(3), 2012, 591-597.

Reference

  1. International Conference for Harmonization, Q2 (R1), Harmonized tripartite guidelines, validation of analytical procedures: text and methodology, Geneva, 2005;1-13.
  2. Martindale: The complete drug reference. Metoprolol Monograph – The pharmaceutical press 2007.
  3. Shashank Soni., Veerma Ram., Divya Verma., Anurag Verma., et.al. Analytical Method Development And Validation of Metoprolol Succinate by HPLC and UV Spectroscopy Technique. Research J. pharm an Tech.2021;14(2):937.doi.10.5958/0974-360X.2021.00166.9.
  4. Hemangi Somnath Chaudhari.,javesh K.Patil.,et.al. A Novel RP-HPLC Method for the Development and validation of Metoprolol Succinate in Bulk and Pharmaceutical Dosage Form. Asian Journal of pharmaceutical Analysis. 2025; doi.10.52711/2231-5675.2025.00045.
  5. Santhosh Kumar Bhardwaj.,K.Dwivedi and D.D.Agarwal.,et.al. A Review HPLC Method Development and Validation. International Journal of Analytical and Bioanalytical Chemistry.2015;5(4):76-81.
  6. Sathe SR, Bari SB, Surana SJ. Development of HPTLC method for the estimation of Metoprolol succinate in bulk and in tablet dosage form. Indian J.Pharm. Educ. Res., 42(1):32-35, 2008.
  7. Vaijanath GD, Sweta BS, et al, Simultaneous determination of Metoprolol succinate and Amlodipine besylate in pharmaceutical dosage form by HPLC, Journal of Pharmaceutical and Biomedical Analysis, 2008, 46(3),583–586.55.
  8. Singh B, Patel DK and Ghosh SK, Development of Reverse-Phase HPLC Method for Simultaneous Analysis of Metoprolol Succinate and Hydrochlorothiazide in a Tablet Formulation, Tropical Journal of Pharmaceutical Research, 2009, 8(6),539-543.
  9. Rajamanickam V, Stephen RB, et al, A validated RP-HPLC method of Metoprolol Succinate and Amlodipine Succinate from bulk drugs, Scholars Research Library, Der Pharmacia Lettre 2010, 2(4), 40-6.
  10. Al ARM, Spoorthy N, et al, Simultaneous estimation of Metoprolol succinate & Telmisartan in tablet dosage form by RP-HPLC, Journal of Pharmacy Research, 2012, 5(8), 4585.
  11.  Mitesh DP and Purnima DH, A Validated and Simplified RP-HPLC of Metoprolol Succinate from Bulk Drugs, Asian J. Research Chem, 2009,2(2),119-122.
  12. Prasad Rao CHMM, Rahaman SA, et al, RP-HPLC method of simultaneous estimation of Amlodipine besylate and Metoprolol in combined dosage form, International Journal of Pharma Research and Development, 2010, 2(9), 69-76.
  13. Mitesh DP, Purnima DH. A validated and simplified RPHPLC of Metoprolol succinate from bulk drugs. Asian Journal Research Chem 2009; 2(2): 119-122
  14. Aqil M, Ali A, Ahad A, Sultana Y, Najmi AK, Saha N. A validated HPLC method for estimation of metoprolol in human plasma. Acta Chromatographic a 2007; 19: 130-40.
  15. Sohan S Chitlange, Ramesh D Bhusil, Monesh B Nikumbh and Rithesh P Bhole, Development and validation of Spectrophotometric and stability indicating RP-HPLC Method for the simultaneous estimation of Metoprolol Succinate and Hydrochlorothiazide in tablet dosage form, International journal of pharmacy, 2(3), 2012, 591-597.

Photo
Murugesan S
Corresponding author

Arunai College of Pharmacy, Tiruvannamalai, India

Photo
Senthil Kumar S. K.
Co-author

Arunai College of Pharmacy, Tiruvannamalai, India

Photo
Rajasri V
Co-author

Arunai College of Pharmacy, Tiruvannamalai, India

Photo
Rajeshkumar D
Co-author

Arunai College of Pharmacy, Tiruvannamalai, India

Photo
Reshma S
Co-author

Arunai College of Pharmacy, Tiruvannamalai, India

Photo
Rohini S
Co-author

Arunai College of Pharmacy, Tiruvannamalai, India

Photo
Sahana P
Co-author

Arunai College of Pharmacy, Tiruvannamalai, India

Murugesan S, Senthil Kumar S. K., Rajasri V, Rajeshkumar D, Reshma S, Rohini S, Sahana P, Method Development and Validation of Metoprolol Succinate by RP-HPLC Method, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 2, 4534-4544. https://doi.org/10.5281/zenodo.18810817

More related articles
A Comprehensive Review on The Pharmacological Pote...
Yogini Raut, Dr. Anjali Wankhade, Dr. Vivek Paithankar, ...
Evaluation Of Antiulcer Activity of Ativisha by Et...
Vishnu Patil, Mahesh Dhumal, Shantanu Mane, ...
Formulation Optimization and Evaluation of Herbal ...
Kamlesh Garate, Priyanka Waghmare, Monika Bankar, Prashant Jichka...
Evaluation And Management Of Urolithiasis...
Pittu Vishnu Priya, Palle Sai Sharanya, Nanubothula Kushala Yadav, Gangavarapu Hari Priya, Kurva Nav...
Niosomes: A Review Of Drug Delivery System...
Pradnya H. Kapse, Vrushali S. Gangurde, Khanderao Jadhav, Rishikesh Bachhav, ...
Exploring Formulation Strategies And Assessing Efficacy: A Study On Hand Wash De...
Pallavi N. Somthane, Vedantika R. Salunkhe, Vedant Mulange, Vighnesha Gawari, ...
Related Articles
Tacrolimus: An Updated Review on Pharmacological, Pharmacodynamic, Pharmacokinet...
Mohd. Akhtar, Sajad Khaliq Dar, Arshad H. Khuroo, Sudershan Kumar, Chandni Sharma, ...
Desin And Development of Immediate Release Tablet Using Kollidon 90f As Carrier...
Pruthviraj Kale , Atish velhal , P. D. Jadhav, V. K. Redasani, Monika sabale , ...
A Comprehensive Review on The Pharmacological Potential of Salvia Splendens...
Yogini Raut, Dr. Anjali Wankhade, Dr. Vivek Paithankar, ...
More related articles
A Comprehensive Review on The Pharmacological Potential of Salvia Splendens...
Yogini Raut, Dr. Anjali Wankhade, Dr. Vivek Paithankar, ...
Formulation Optimization and Evaluation of Herbal Ointment...
Kamlesh Garate, Priyanka Waghmare, Monika Bankar, Prashant Jichkar, Pratik Dhole , Salman Khan Patha...
A Comprehensive Review on The Pharmacological Potential of Salvia Splendens...
Yogini Raut, Dr. Anjali Wankhade, Dr. Vivek Paithankar, ...
Formulation Optimization and Evaluation of Herbal Ointment...
Kamlesh Garate, Priyanka Waghmare, Monika Bankar, Prashant Jichkar, Pratik Dhole , Salman Khan Patha...